Despite initial controversy over expression levels and roles of the adhesion protein JAM-A in invasive breast cancer [27], the balance of evidence has favored correlations between JAM-A overexpression and poor patient prognosis [8,10,11,12,13]. The gene discussed is F11R; the disease is invasive breast carcinoma.